Manu Prasad

634 total citations
27 papers, 359 citations indexed

About

Manu Prasad is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Manu Prasad has authored 27 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Manu Prasad's work include Lung Cancer Treatments and Mutations (6 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and NF-κB Signaling Pathways (4 papers). Manu Prasad is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and NF-κB Signaling Pathways (4 papers). Manu Prasad collaborates with scholars based in Israel, United States and India. Manu Prasad's co-authors include Moshe Elkabets, Jonathan Zorea, Limor Cohen, Ksenia M. Yegodayev, Barak Rotblat, Ben‐Zion Joshua, S. Asha Nair, Sankar Jagadeeshan, Ofra Novoplansky and Susmita Ghosh and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Manu Prasad

24 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manu Prasad Israel 12 183 146 83 59 54 27 359
Shengyu Wu China 12 151 0.8× 128 0.9× 70 0.8× 72 1.2× 39 0.7× 29 347
Renba Liang China 10 212 1.2× 145 1.0× 150 1.8× 53 0.9× 57 1.1× 14 400
Huirong Ding China 11 173 0.9× 110 0.8× 77 0.9× 51 0.9× 57 1.1× 23 376
Marko Kornmann Germany 10 179 1.0× 178 1.2× 78 0.9× 63 1.1× 40 0.7× 26 375
Marta Popęda Poland 13 156 0.9× 142 1.0× 87 1.0× 79 1.3× 52 1.0× 32 350
Sulsal Haque United States 6 168 0.9× 148 1.0× 89 1.1× 62 1.1× 58 1.1× 15 346
Shukai Yuan China 10 146 0.8× 124 0.8× 97 1.2× 37 0.6× 55 1.0× 16 372
Bowen Yuan China 8 301 1.6× 137 0.9× 103 1.2× 75 1.3× 29 0.5× 14 418
Jiuliang Yan China 11 133 0.7× 139 1.0× 95 1.1× 73 1.2× 113 2.1× 18 351
Tianliang Xia China 12 241 1.3× 119 0.8× 125 1.5× 81 1.4× 44 0.8× 21 366

Countries citing papers authored by Manu Prasad

Since Specialization
Citations

This map shows the geographic impact of Manu Prasad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manu Prasad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manu Prasad more than expected).

Fields of papers citing papers by Manu Prasad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manu Prasad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manu Prasad. The network helps show where Manu Prasad may publish in the future.

Co-authorship network of co-authors of Manu Prasad

This figure shows the co-authorship network connecting the top 25 collaborators of Manu Prasad. A scholar is included among the top collaborators of Manu Prasad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manu Prasad. Manu Prasad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jagadeeshan, Sankar, Manu Prasad, Noam Erez, et al.. (2025). Anti-PD1 prolongs the response of PI3K and farnesyl transferase inhibition in HRAS- and PIK3CA-mutant head and neck cancers. Neoplasia. 63. 101157–101157. 1 indexed citations
2.
Vos, Joris L., Stanley Z. Lam, Catherine Y. Han, et al.. (2025). Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic dissemination. Nature Genetics. 57(6). 1504–1511. 1 indexed citations
3.
4.
Novoplansky, Ofra, Sankar Jagadeeshan, Manu Prasad, et al.. (2024). Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 308–308. 1 indexed citations
5.
Novoplansky, Ofra, Sankar Jagadeeshan, Jonathan Zorea, et al.. (2023). Activation of the EGFR / PI3K / AKT pathway limits the efficacy of trametinib treatment in head and neck cancer. Molecular Oncology. 17(12). 2618–2636. 19 indexed citations
6.
Goldbart, Riki, et al.. (2021). Quaternized Starch-Based Composite Nanoparticles for siRNA Delivery to Tumors. ACS Applied Nano Materials. 4(2). 2218–2229. 8 indexed citations
7.
Singh, Ashish, Manu Prasad, Nirmal Vivek Raut, et al.. (2021). Treatment pattern and outcomes of leptomeningeal carcinomatosis in India: CRSF201901 study.. Journal of Clinical Oncology. 39(15_suppl). e14012–e14012.
8.
Prasad, Manu, Joel S. Brown, Moshe Elkabets, et al.. (2021). Using Free-Range Laboratory Mice to Explore Foraging, Lifestyle, and Diet Issues in Cancer. Frontiers in Ecology and Evolution. 9. 5 indexed citations
9.
Yegodayev, Ksenia M., Ofra Novoplansky, Manu Prasad, et al.. (2020). TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer. Cancers. 12(2). 339–339. 47 indexed citations
10.
Prasad, Manu, Sankar Jagadeeshan, Maurizio Scaltriti, Irit Allon, & Moshe Elkabets. (2020). In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System. Journal of Visualized Experiments.
11.
Ghosh, Susmita, Manu Prasad, Kiran Kundu, et al.. (2019). Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy. Frontiers in Oncology. 9. 17–17. 19 indexed citations
12.
Jagadeeshan, Sankar, Manu Prasad, Sandra Ortiz‐Cuaran, et al.. (2019). Adaptive Responses to Monotherapy in Head and Neck Cancer: Interventions for Rationale-Based Therapeutic Combinations. Trends in cancer. 5(6). 365–390. 11 indexed citations
13.
Prasad, Manu, Jonathan Zorea, Ksenia M. Yegodayev, et al.. (2019). Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy. JCI Insight. 4(8). 45 indexed citations
14.
15.
Krelin, Yakov, Manu Prasad, Moshe Elkabets, et al.. (2019). The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma cells. International Journal of Cancer. 145(12). 3402–3413. 28 indexed citations
16.
Zorea, Jonathan, Manu Prasad, Limor Cohen, et al.. (2018). IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer. Cell Death and Disease. 9(10). 944–944. 37 indexed citations
17.
Kalathil, Dhanya, et al.. (2018). Thiostrepton degrades mutant p53 by eliciting an autophagic response in SW480 cells. Journal of Cellular Physiology. 233(10). 6938–6950. 7 indexed citations
18.
Ambili, R., P. S. Saneesh Babu, Manu Prasad, et al.. (2017). Differential expression of transcription factors NF-κB and STAT3 in periodontal ligament fibroblasts and gingiva of healthy and diseased individuals. Archives of Oral Biology. 82. 19–26. 16 indexed citations
19.
20.
Prasad, Manu, et al.. (2009). Liquid nitrogen cryotherapy in the management of oral lesions: a retrospective clinical study. Journal of Maxillofacial and Oral Surgery. 8(1). 40–42. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengyu Wu Breakdown of academic impact, for papers by Renba Liang Breakdown of academic impact, for papers by Huirong Ding Breakdown of academic impact, for papers by Marko Kornmann Breakdown of academic impact, for papers by Marta Popęda Breakdown of academic impact, for papers by Sulsal Haque Breakdown of academic impact, for papers by Shukai Yuan Breakdown of academic impact, for papers by Bowen Yuan Breakdown of academic impact, for papers by Jiuliang Yan Breakdown of academic impact, for papers by Tianliang Xia
Rankless by CCL
2026